Conclusion - adverse effects of Hormonal contraception

Large   investiments   are   being   made   focalized   on   prevention   of   unwilling pregnancy and sexually transmitted disease in several countries, but the relevance of the problem requires the interest at international political levels. Contraception is a crucial human right for its role in health, development and quality of life. In spite of shortcomings of currently available male contraception, 1/3 of the couples that use contraception worldwide rely on male methods,  suggesting that the development of a safe, effective, reversible and affordable contraceptive method for   men   would   meet   a   critical   need(16). Because   rates   of   unintended pregnancy, abortion and unintended birth are very high among adult women in the United   States, it   is   important   to   identify   interventions   that   can   increase contraceptive use in the population, such as vaccines. Currently, vaccines are still experimental and until now were tested in animal and in women of developing countries(17,18). A research plan that rigorously assesses the impact of different approaches to increasing contraceptive use among adult and young women, should be an integral part of any long-term effort to prevent unintended pregnancy(19)

Rosa Sabatini and Raffele Cagiano
Department of Obstetrics and Gynecology
Department of Pharmacology General Hospital Policlinico-University of Bari, Italy


  1. Erkkola R. (2006). Recent advances in contraception.  Minerva Ginecol, 58(4), 295-305. 
  2. Grimes D.A. (2003). Unsafe abortion: the silent scourge. Br.Med.Bull,  67, 99-113.
  3. Okonofua F.(2006). Abortion and maternal mortality in the developing world. J. Obstet. Gynaecol. Can, 28(11),974-9.[4] Fawcus,S.R. (2008). Maternal mortality and unsafe abortion. Best Pract. Res. Clin. Obstet. Gynaecol, 22(3), 533-48.
  4. Economidis M.A.,  Mishell D.R. Jr. (2005). Pharmacological   female contraception: an overview of past and future use. Expert Opin. Invastig. Drugs, 14(4), 449-56. 
  5. Benagiano G., Bastianelli C., Farris M. Contraception today. Ann. N.Y.Acad. Sci.2006; 1092; 1-32.
  6. Cheung E., Free, C. (2005). Factors influencing young women’s decision-making regarding hormonal contraceptives: a qualitative study. Contraception, 71, 426-31.
  7. Seifert-Klauss V., Kaemmerer H., Brunner B., Schneider K.T., Hess, J. (2000). Contraception in patients with congenital heart defects. Z.Kardiol, 89(7), 606-11. 
  8. Teal S.B., Ginosar D.M.  (2007). Contraception for women with chronic medical conditions. Obstet. Gynecol. Clin. North Am,34(1), 113- 26. 
  9. Tong H.K., Fai G.L., Ann L.T., Hock O.B. (1981). Budd-Chiari syndrome and hepatic adenomas associated with oral contraceptives. A case report. Singapore Med. J, 22(3), 168-72. 
  10. Shilling M.K., Zimmermann A., Radaelli C., Seiler C.A., Buchler M.W. (2000). Liver nodules resembling focal nodular hyperplasia after hepatic venous thrombosis. J.Hepatol, 33(4),673-6.
  11. Jungers P., Dougados M., Pelissier C., Kuttenn F., Tron F., Pertuiset N., Bach J.F. (1982). Effect of hormonal contraception on the course of lupus nephropathy. Nouv. Presse Med, 11(51), 3765-8.
  12. Lakasing L., Khamashta M. (2001). Contraceptive practices in women with systemic   lupus   erythematous   and/or   antiphospholipid   syndrome: what advice should we be giving?  J.Fam.  Plann. Reprod. Health Care,  27(1),  7-12. 
  13. Chengalvala M.V., Meade E.H. Jr, Cottom J.E., Hoffman W.H., Shanno L.K., Wu M.M., Kopf G.S.,  Shen E.S.(2006). Regulation of female fertility and identification of future contraceptive targets. Curr.  Pharm. Des,12(30), 3915-28.
  14. Chabbert-Buffet N., Meduri, G., Bouchard P., Spitz I.M. (2005). Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications. Hum. Reprod. Update, 11(3), 293-307.
  15. Costantino A., Cerpolini S., Perrone A.M., Ghi T., Pelusi C., Pelusi G., Meriggiola M.C.  (2007). Current status and future perspectives in male contraception. Minerva Ginecol, 59(3), 299-310.
  16. Suri A.  (2004). Sperm specific proteins-potential candidate molecules for fertility control. Reprod. Biol. Endocrinol, 2,10.
  17. Chamley L.W., Clarke G.N. (2007).Antisperm   antibodies   and conception. Semin. Immunopathol, 29 (2),169-84
  18. Kirby D.  (2008). The impact of programs to increase contraceptive use among adult women:a review of experimental and quasi-experimental studies. Perspect Sex Reprod Health. Mar, 40(1),34-41.

Page 3 of 31 2 3

Provided by ArmMed Media